期刊文献+

LYRIC在人肝癌组织中的表达及其临床意义

LYRIC in hepatocellular carcinoma: Expression and potential prognostic significance
下载PDF
导出
摘要 目的:检测LYRIC分子在肝癌和癌旁组织中的表达,探讨LYRIC分子与肝癌患者临床病理特征的关系及其对预后判断的指导意义。方法:收集2005年1月至2013年12月沈阳军区总医院和中国医科大学附属盛京医院的87例肝癌患者肝癌及其癌旁组织切除标本,采用Real-time PCR和免疫组织化学染色等方法从基因和蛋白水平检测肝癌患者的癌组织及相应的癌旁组织中LYRIC分子的表达,结合患者病理指标、病理分型和预后随访资料分析LYRIC分子表达的临床意义。结果:在基因水平检测发现,LYRIC基因在56例肝癌组织中表达高于癌旁组织,高表达率为64.7%(56/87);在蛋白水平检测发现,LYRIC蛋白在87例肝癌组织中均表达,且在肝癌组织中的表达显著高于癌旁组织(2.16±0.87 vs 1.63±0.88,P=0.000 1)。在肝癌组织中LYRIC分子的高、低表达可较好地预测肝癌患者的预后情况,LYRIC分子高表达患者预后较差(Log-rank10.236,P=0.001);多因素分析提示,LYRIC高表达(HR=2.19)、转移(HR=2.44)及肿瘤分期(HR=2.01)是影响肝癌总体生存期的独立危险因素,而与肿瘤直径及是否有病毒感染无关。结论:LYRIC分子在肝癌组织中高表达,且其表达水平与肝癌的临床分期、转移能力和临床预后密切相关,是肝癌潜在的预后判断指标。 Objective: To determine the expression profile of lysine-rich CEACAM1 coisolated( LYRIC) in hepatocellular carcinoma( HCC) and matched adjacent normal liver tissue. Methods: Matched biopsy specimens of the tumor proper and the corresponding adjacent normal mucosa were collected from 87 HCC patients who underwent surgical resection in China Medical University-Affiliated Shengjing Hospital and General Hospital of Shenyang Military Region. LYRIC mRNA and protein in these specimens were assessed by realtime PCR and immunohistochemical staining. The potential significance of LYRIC mRNA and protein level measurements in the prognosis of HCC were evaluated by multivariate analysis. Results: In 56( 64. 7%) of the 87 matched specimens,LYRIC mRNA was significantly higher in HCC than in the adjacent mucosa. LYRIC protein was detected in both HCC and adjacent normal tissue in all 87 cases,but the level wassignificantly higher( P〈 0. 001) in HCC( 2. 16 ± 0. 87) than in adjacent normal tissue( 1. 63 ± 0. 88). Enhanced LYRIC expression was associated with poor prognosis( Log-rank10. 236,P = 0. 001). Metastasis( HR = 2. 44),elevated LYRIC expression( HR = 2. 19) in HCC and tumor stage( HR = 2. 01) were independent risk factors of overall survival.In contrast,overall survival was not associated with tumor diameters and virus infection. Conclusion: LYRIC expression is significantly up-regulated in HCC as compared with normal liver tissue. Both LYRIC mRNA and protein levels in HCC are closely associated with the molecular subtype and staging of the tumor,prognosis,suggesting that LYRIC may serve as a potential prognostic factor of liver cancer.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2014年第5期565-569,共5页 Chinese Journal of Cancer Biotherapy
基金 科技部"十二五"重大新药创制平台子课题(No.2012ZX09303016-002) 辽宁省科技攻关计划课题(No.2012225019)~~
关键词 LYRIC 肝癌 预后 LYRIC hepatocellular carcinoma(HCC) prognosis
  • 相关文献

参考文献14

  • 1Wong TC, Poon RT. Hepatobiliary malignancies: Lessons from Asia [J]. Dig Dis 2013; 31(1): 130-137.
  • 2Banin Hirata BK, Oda JM, Losi Guembarovski R, et al. Molecu- lar markers for breast cancer: Prediction on tumor behavior [ J ]. Dis Markers, 2014, 2014(ID513158,12 pages).
  • 3Su ZZ, Kang DC, Chen Y, et al. Identification and cloning of hu- man astroeyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH [ J]. Oncogene, 2002, 21 (22) : 3592-3602.
  • 4Wan L, Kang Y. Pleiotropic roles of AEG-1/MTDH/LYRIC in breast cancer [J]. Adv Cancer Res, 2013, 120(1) : 113-134.
  • 5Meng X, Brachova P, Yang S, et al. Knockdown of MTDH sensi- tizes endometrial cancer cells to cell death induction by death re- ceptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment [J]. PLoS ONE, 2011, 6(6) : e20920.
  • 6Gnosa S, Shen YM, Wang CJ, et al. Expression of AEG-1 mRNA and protein in colorectal cancer patients and ealon cancer cell lines [J]. J Transl Med, 2012, 10(1): 109-112.
  • 7Huang W, Yang L, Liang S, et al. AEG-1 is a target of perifosine and is over-expressed in gastric dysplasia and cancers [ J ]. Dig Dis Sci, 2013, 58(10): 2873-2880.
  • 8Hu G, Wei Y, Kang Y. The multifaeeted role of MTDH/AEG-1 in cancer progression [J]. Clin Cancer Res, 2009, 15 (18): 5615-5620.
  • 9Abdurakhmanov DT. Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis [ J]. Ter Arkh, 2013, 85 (10) : 94-97.
  • 10Altekruse SF, Henley SJ, Cucinelli JE, et al. Changing hepatocel- lular carcinoma incidence and liver cancer mortality rates in the u- nited states [J]. Am J Gastroenterol, 2014, 109(4) : 524-553.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部